CIBC World Markets Inc. bought a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 34,243 shares of the pharmacy operator’s stock, valued at approximately $2,682,000.
Other large investors have also bought and sold shares of the company. RB Capital Management LLC boosted its position in shares of Walgreens Boots Alliance by 25.8% in the first quarter. RB Capital Management LLC now owns 3,969 shares of the pharmacy operator’s stock worth $330,000 after acquiring an additional 813 shares during the last quarter. Karp Capital Management Corp acquired a new position in Walgreens Boots Alliance during the first quarter valued at approximately $30,227,000. First Foundation Advisors raised its stake in shares of Walgreens Boots Alliance by 40.2% during the first quarter. First Foundation Advisors now owns 21,037 shares of the pharmacy operator’s stock valued at $1,747,000 after purchasing an additional 6,032 shares during the period. FormulaFolio Investments LLC purchased a new stake in shares of Walgreens Boots Alliance during the first quarter valued at approximately $292,000. Finally, Parkwood LLC raised its stake in shares of Walgreens Boots Alliance by 62.6% during the first quarter. Parkwood LLC now owns 40,735 shares of the pharmacy operator’s stock valued at $3,383,000 after purchasing an additional 15,690 shares during the period. Hedge funds and other institutional investors own 63.58% of the company’s stock.
In other Walgreens Boots Alliance news, Director John Anthony Lederer bought 20,000 shares of the business’s stock in a transaction that occurred on Thursday, October 26th. The shares were bought at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the transaction, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the transaction, the director now owns 16,415 shares in the company, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. 13.50% of the stock is currently owned by insiders.
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at $70.37 on Tuesday. The company has a market capitalization of $71,667.88, a P/E ratio of 13.92, a PEG ratio of 1.26 and a beta of 1.20. Walgreens Boots Alliance, Inc. has a one year low of $63.82 and a one year high of $88.00. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.21 by $0.10. The business had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.07 EPS. research analysts anticipate that Walgreens Boots Alliance, Inc. will post 5.55 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.27%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 42.33%.
Walgreens Boots Alliance announced that its Board of Directors has approved a share buyback plan on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to repurchase shares of its stock through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its stock is undervalued.
WBA has been the subject of a number of research analyst reports. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday. Citigroup Inc. lowered their target price on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating for the company in a research note on Thursday, November 2nd. Leerink Swann downgraded shares of Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 1st. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Monday, October 30th. Finally, Jefferies Group LLC set a $93.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Sunday, October 29th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $87.63.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.